GENE ONLINE|News &
Opinion
Blog

FDA Approved
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
2022-03-29
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
2021-03-20
R&D
Merck Bets Big on Seattle Genetics for Two Oncology Drugs
2020-09-16
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
NERLYNX-XELODA Combo Bags FDA Approval for HER2 Positive Breast Cancer Treatment
2020-02-27
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top